Integra LifeSciences

Integra LifeSciences, a leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. 
Company Growth (employees)
Plainsboro Center, US
Size (employees)
3,700 (est)+6%
Integra LifeSciences is headquartered in Plainsboro Center, US

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Plainsboro Center, Oakville, York, Billerica and in 1 other location
Plainsboro Center, US (HQ)
311 Enterprise Dr
West Valley City, US
3498 W 2400 S
Billerica, US
85 Rangeway Rd
York, US
589 Davies Dr
Oakville, CA
2590 Bristol Cir

Integra LifeSciences Data and Metrics

Integra LifeSciences Financial Metrics

Integra LifeSciences's revenue was reported to be $992.1 m in FY, 2016 which is a 12% increase from the previous period.
$, USD

Revenue (FY, 2016)

992.1 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

643 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

74.6 m

EBIT (FY, 2016)

115.3 m

Market capitalization (23-Jun-2017)

4.1 b

Closing share price (23-Jun-2017)


Cash (31-Dec-2016)

102.1 m
Integra LifeSciences's current market capitalization is $4.1 b.
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


836.2 m928.3 m882.7 m992.1 m

Revenue growth, %


Cost of goods sold

334.1 m352.8 m326.5 m349.1 m

Gross profit

502.1 m575.5 m556.2 m643 m

Gross profit Margin, %


Operating expense total

505.8 m510 m476.6 m876.7 m


(3.6 m)65.5 m79.6 m115.3 m

EBIT margin, %


Interest expense

(19.8 m)(22 m)(23.5 m)(25.8 m)

Interest income

443 k168 k13 k24 k

Pre tax profit

(24.8 m)43 m60.7 m90.4 m

Income tax expense

(7.8 m)9 m53.8 m15.8 m

Net Income

(17 m)34 m(3.5 m)74.6 m
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


120.6 m72 m48.1 m102.1 m


26.8 m29.6 m42.6 m27.7 m

Current Assets

525.2 m529.3 m438.5 m495.2 m


200.3 m210 m205.2 m222.4 m


249.8 m363.9 m512.4 m510.6 m

Total Assets

1.2 b1.6 b1.8 b1.8 b

Current Liabilities

119.4 m126 m139.1 m123.6 m

Additional Paid-in Capital

779.6 m1 b798.7 m

Retained Earnings

285 m315 m145.9 m220.4 m

Total Equity

751.4 m839.7 m

Financial Leverage

2.4 x2.2 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(17 m)34 m(3.5 m)74.6 m

Depreciation and Amortization

47 m61.1 m58.9 m72.7 m

Accounts Receivable

(2.9 m)(16 m)(16 m)(18 m)


(42 m)(27 m)(3.8 m)(9.6 m)

Cash From Operating Activities

53.3 m79.5 m94.5 m116.4 m

Purchases of PP&E

(47.9 m)(41.9 m)(33.4 m)(47.3 m)

Cash From Investing Activities

(50.3 m)(363.3 m)(372 m)(42.6 m)

Cash From Financing Activities

19 m242.8 m258.5 m(15.1 m)
Y, 2016

Financial Leverage

2.2 x

Integra LifeSciences Market Value History

Integra LifeSciences Online and Social Media Presence

Integra LifeSciences Company Life and Culture

You may also be interested in